Hirosaki University · Graduate School of Medicine

Research keywordsEnterococcus faecium phage therapy・antibiofilm activity・sepsis management・antimicrobial stewardship・persistent idiopathic dentoalveolar pain・3-hydroxybutyrate biomarker

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Characterization of phage vB_EfS_C1 and investigation of antibacterial and antibiofilm properties against vancomycin-susceptible and vancomycin-resistant Enterococcus faecium.2025 · Virology 612 ( 110685 ) 2025年09月
• Multiple Blood Culture Sampling, Proper Antimicrobial Choice, and Adequate Dose in Definitive Therapy Supported by the Antimicrobial Stewardship Team Could Decrease 30-Day Sepsis Mortality Rates2024 · Infection and Drug Resistance 17 207 - 219 2024年01月
• 休み時間の感染症学2023 · 講談社サイエンティフィク 2023年10月
• Serum 3-Hydroxybutyrate is Expected to Serve as One of the Supportive Diagnostic Markers of Persistent Idiopathic Dentoalveolar Pain (PDAP)2023 · J Pain Res 2023年11月

• Official profile